Showing results (201-210 of 239) with videos related to

Sort By:
Pageof 24
The New England Journal of Medicine|August 16, 2002
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumorsGeorge D Demetri, Margaret von Mehren, Charles D Blanke, et al.
Cell|April 28, 2023
Cachexia: A systemic consequence of progressive, unresolved diseaseMiriam Ferrer, Tracy G Anthony, Janelle S Ayres, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2023
Myo-differentiation reporter screen reveals NF-Y as an activator of PAX3-FOXO1 in rhabdomyosarcomaMartyna W Sroka, Damianos Skopelitis, Marit W Vermunt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2022
Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment ResponseToni T Seppälä, Jacquelyn W Zimmerman, Reecha Suri, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 19, 2023
Engrailed-1 Promotes Pancreatic Cancer MetastasisJihao Xu, Jae-Seok Roe, EunJung Lee, et al.
Communications Biology|April 9, 2024
Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactionsKelly Boelaars, Ernesto Rodriguez, Zowi R Huinen, et al.
Nature|March 13, 2025
MYC ecDNA promotes intratumour heterogeneity and plasticity in PDACElena Fiorini, Antonia Malinova, Daniel Schreyer, et al.
Cell|August 2, 2016
NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic CancerIok In Christine Chio, Seyed Mehdi Jafarnejad, Mariano Ponz-Sarvise, et al.
Cancer Cell|October 21, 2022
A path to translation: How 3D patient tumor avatars enable next generation precision oncologyShree Bose, Margarida Barroso, Milan G Chheda, et al.
Cell|August 1, 2017
Enhancer Reprogramming Promotes Pancreatic Cancer MetastasisJae-Seok Roe, Chang-Il Hwang, Tim D D Somerville, et al.
Pageof 24